{"id":89792,"date":"2026-01-13T00:41:11","date_gmt":"2026-01-13T00:41:11","guid":{"rendered":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/13\/piramal-pharma-enhances-its-global-sustainability-rating-in-recent-corporate-assessment\/"},"modified":"2026-01-13T00:41:11","modified_gmt":"2026-01-13T00:41:11","slug":"piramal-pharma-enhances-its-global-sustainability-rating-in-recent-corporate-assessment","status":"publish","type":"post","link":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/13\/piramal-pharma-enhances-its-global-sustainability-rating-in-recent-corporate-assessment\/","title":{"rendered":"Piramal Pharma Enhances Its Global Sustainability Rating in Recent Corporate Assessment."},"content":{"rendered":"

Piramal Pharma, a leading global pharmaceutical company, has achieved a significant improvement in its score on the Global Corporate Sustainability Assessment (CSA) conducted by S&P Global. The CSA is a widely recognized benchmark for assessing a company’s sustainability performance, evaluating factors such as environmental, social, and governance (ESG) practices.<\/p>\n

In the latest assessment, Piramal Pharma’s score has increased by 13 points, reaching a total of 73 out of 100. This improvement reflects the company’s ongoing efforts to integrate sustainability into its business strategy and operations. The CSA assessment is based on a comprehensive evaluation of a company’s sustainability practices, including climate change, human rights, labor practices, and corporate governance.<\/p>\n

The significant improvement in Piramal Pharma’s score can be attributed to its focused efforts on reducing its environmental footprint, enhancing its governance practices, and promoting social responsibility. Some of the key initiatives that contributed to this improvement include:<\/p>\n

    \n
  1. Renewable energy<\/strong>: Piramal Pharma has increased its use of renewable energy sources, such as solar and wind power, to reduce its dependence on fossil fuels and lower its carbon emissions.<\/li>\n
  2. Water conservation<\/strong>: The company has implemented water-saving measures and efficient wastewater management systems to minimize its water footprint.<\/li>\n
  3. Waste reduction<\/strong>: Piramal Pharma has implemented a waste reduction program, which includes recycling and composting, to minimize waste disposal and reduce its environmental impact.<\/li>\n
  4. Corporate governance<\/strong>: The company has strengthened its corporate governance practices, including board composition, executive compensation, and auditing practices.<\/li>\n
  5. Social responsibility<\/strong>: Piramal Pharma has continued to invest in social responsibility initiatives, such as education, healthcare, and community development programs, to promote positive social impact.<\/li>\n<\/ol>\n

    The improved score on the Global Corporate Sustainability Assessment reflects Piramal Pharma’s commitment to sustainability and its efforts to create long-term value for its stakeholders. The company’s focus on sustainability is aligned with its mission to improve the quality of life for patients and communities worldwide. By integrating sustainability into its business strategy, Piramal Pharma aims to minimize its environmental footprint, promote social responsibility, and ensure long-term success.<\/p>\n

    Overall, Piramal Pharma’s achievement on the Global Corporate Sustainability Assessment demonstrates its dedication to sustainability and its commitment to creating a positive impact on the environment, society, and the economy. The company’s improved score serves as a testament to its efforts to balance business growth with social and environmental responsibility, making it a leader in the pharmaceutical industry.<\/p>\n","protected":false},"excerpt":{"rendered":"

    Piramal Pharma, a leading global pharmaceutical company, has achieved a significant improvement in its score on the Global Corporate Sustainability Assessment (CSA) conducted by S&P Global. The CSA is a widely recognized benchmark for assessing a company’s sustainability performance, evaluating factors such as environmental, social, and governance (ESG) practices. In the latest assessment, Piramal Pharma’s […]<\/p>\n","protected":false},"author":1,"featured_media":88139,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[2,27],"tags":[],"class_list":["post-89792","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma","category-piramal-pharma"],"jetpack_featured_media_url":"https:\/\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89848,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/24\/lupin-earns-top-cdp-a-rating-for-efforts-in-combating-climate-change-and-conserving-water\/","url_meta":{"origin":89792,"position":0},"title":"Lupin Earns Top CDP A Rating for Efforts in Combating Climate Change and Conserving Water","author":"Team Small News","date":"January 24, 2026","format":false,"excerpt":"Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest 'A' leadership rating from the Climate Disclosure Project (CDP) for its exceptional performance in Climate Change and Water Security. This recognition is a testament to Lupin's commitment to sustainability and transparency,\u2026","rel":"","context":"In "Lupin"","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89907,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/02\/06\/piramal-critical-care-collaborates-with-blue-zone-to-launch-innovative-waste-anaesthetic-gas-recycling-initiative\/","url_meta":{"origin":89792,"position":1},"title":"Piramal Critical Care collaborates with Blue-Zone to launch innovative waste anaesthetic gas recycling initiative.","author":"Team Small News","date":"February 6, 2026","format":false,"excerpt":"Piramal Critical Care, a leading provider of inhalation anaesthetics, has partnered with Blue-Zone Technologies, a pioneer in anaesthetic gas recycling, to launch a groundbreaking initiative aimed at reducing the environmental impact of waste anaesthetic gases. This innovative collaboration seeks to address the significant problem of anaesthetic gas waste, which contributes\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":89777,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/10\/jefferies-names-sai-life-and-divis-labs-as-top-choices-in-the-contract-research-and-development-manufacturing-organization-crdmo-sector-while-reducing-target-prices-for-piramal-pharma-and-cohance\/","url_meta":{"origin":89792,"position":2},"title":"Jefferies names Sai Life and Divi’s Labs as top choices in the contract research and development manufacturing organization (CRDMO) sector, while reducing target prices for Piramal Pharma and Cohance.","author":"Team Small News","date":"January 10, 2026","format":false,"excerpt":"Jefferies, a global investment bank, has released its latest report on the Contract Research and Development Manufacturing Organization (CRDMO) sector. The report highlights top picks and revises target prices for several key players in the industry. Sai Life Sciences and Divi's Labs have emerged as Jefferies' top picks in the\u2026","rel":"","context":"In "Divi's Laboratories"","block_context":{"text":"Divi's Laboratories","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/divis-laboratories\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":89844,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/23\/lupin-achieves-top-esg-score-from-cdp-for-efforts-in-combating-climate-change-and-ensuring-water-security-reported-by-chennai-patrika\/","url_meta":{"origin":89792,"position":3},"title":"Lupin Achieves Top ESG Score from CDP for Efforts in Combating Climate Change and Ensuring Water Security – Reported by Chennai Patrika.","author":"Team Small News","date":"January 23, 2026","format":false,"excerpt":"Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest 'A' leadership rating from the Climate Disclosure Project (CDP) for its exceptional accomplishments in Climate Change and Water Security. This recognition solidifies Lupin's position as a global leader in championing sustainability\u2026","rel":"","context":"In "Lupin"","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89870,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/27\/lupin-achieves-top-esg-rating-from-cdp-for-its-efforts-in-addressing-climate-change-and-water-security\/","url_meta":{"origin":89792,"position":4},"title":"Lupin achieves top ESG rating from CDP for its efforts in addressing climate change and water security.","author":"Team Small News","date":"January 27, 2026","format":false,"excerpt":"Lupin, a global pharmaceutical leader, has been recognized for its exceptional sustainability efforts, receiving the highest \"A\" leadership rating from the Climate Disclosure Project (CDP) for both Climate Change and Water Security. This prestigious recognition solidifies Lupin's position among the world's most sustainable and transparent companies. The double \"A\" rating\u2026","rel":"","context":"In "Lupin"","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89855,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/25\/lupin-achieves-prestigious-cdp-double-a-rating-for-excellence-in-climate-change-mitigation-and-water-stewardship\/","url_meta":{"origin":89792,"position":5},"title":"Lupin Achieves Prestigious CDP Double ‘A’ Rating for Excellence in Climate Change Mitigation and Water Stewardship","author":"Team Small News","date":"January 25, 2026","format":false,"excerpt":"Lupin, a global pharmaceutical company, has achieved a significant milestone in its sustainability journey by earning a double 'A' rating from CDP (formerly known as the Carbon Disclosure Project) for its leadership in climate action and water security. This prestigious rating recognizes Lupin's efforts to reduce its environmental impact and\u2026","rel":"","context":"In "Lupin"","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89792"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89792\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media\/88139"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}